Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
184B5
NM
Basal
GSK461364
PLK1
PLK
9095.001
uM
0.17731
2.57920
-0.9719 -1.0000 0.4103 0.4637
0.7474
1.0444
184B5
NM
Basal
GSK923295
CENPE
Kinesin
9095.001
uM
1.82040
10.84810
-0.6893 -1.0000 0.6155 0.3102
0.7760
1.0444
184B5
NM
Basal
GW-5074
CRAF
MAPK
5897.088
uM
2.70550
3.11820
-0.1725 -0.1816 2.1826 0.2410
0.9894
1.2950
184B5
NM
Basal
Ibandronate
FDPS
12566.143
uM
246.04810
377.53870
-0.8325 -0.8991 2.4033 0.2099
0.9974
1.6413
184B5
NM
Basal
ICRF-193
TOP2
TOP
12566.171
uM
inf
0.13728
0.6403 0.6293 1.2114 0.1786
0.9288
1.5151
184B5
NM
Basal
IKK16
IKK
NFKB
5897.093
uM
1.73350
2.93910
-0.9487 -0.9879 2.0655 0.4622
0.9967
1.2047
184B5
NM
Basal
Imatinib
ABL/KIT/PDGFR
nRTK
5896.091
uM
23.18150
34.00000
-0.9493 -0.9584 2.7948 0.4637
0.9940
1.4988
184B5
NM
Basal
Imatinib
ABL/KIT/PDGFR
nRTK
5897.091
uM
24.73780
35.23660
-0.9547 -0.9568 3.0230 0.4186
0.9990
1.2296
184B5
NM
Basal
Ispinesib
KSP
Kinesin
5896.067
uM
0.56462
3.31620
-0.9349 -1.0000 0.6205 0.4400
0.9084
1.4536
184B5
NM
Basal
Ispinesib
KSP
Kinesin
5897.067
uM
1.94680
2.77930
-0.9633 -0.9674 3.0241 0.4080
0.9827
1.1908
184B5
NM
Basal
Ixabepilone
TUBB
TUBB
5896.095
uM
0.08255
0.56666
-0.9288 -1.0000 0.5703 0.7131
0.9537
1.5532
184B5
NM
Basal
Ixabepilone
TUBB
TUBB
5897.095
uM
0.20628
0.87310
-0.9665 -1.0000 0.7614 0.6402
0.9623
1.2197
184B5
NM
Basal
JNK-IN-5A
JNK
JNK
12566.168
uM
197.47390
224.21850
0.4789 -0.4434 4.9982 0.0157
0.9558
1.4366
184B5
NM
Basal
L-779450
BRAF
MAPK
12566.166
uM
3.60120
8.28470
-0.5360 -0.8326 1.1766 0.2021
0.9933
1.2010
184B5
NM
Basal
Lapatinib
EGFR/HER2
ErbB
5896.098
uM
19.73470
1.01420
0.5024 0.4466 0.7535 0.1314
0.9743
1.6038
184B5
NM
Basal
LBH589
HDAC
HDAC
12566.167
uM
0.13317
0.57457
-0.4488 -0.6154 0.5488 0.5171
0.9826
1.5941
184B5
NM
Basal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
12566.167
uM
0.40063
1.20680
-0.8855 -1.0000 0.9963 0.5481
0.9929
1.5941
184B5
NM
Basal
Mebendazole
12979.174
uM
inf
0.50538
0.5338 0.6450 4.9853 0.1589
0.6593
1.5680
184B5
NM
Basal
Methotrexate
DHFR
Metabolism
5896.084
uM
0.02683
0.03281
-0.4711 -0.4849 3.3686 1.0619
0.9980
1.5200
184B5
NM
Basal
Methotrexate
DHFR
Metabolism
5897.085
uM
0.04372
0.05133
-0.6179 -0.6153 5.0000 1.1076
0.9993
1.2392
184B5
NM
Basal
MG-132
Proteasome
Proteasome
12566.17
uM
0.01702
0.03186
-0.6444 -0.5157 1.1297 0.9111
0.9667
1.4648
184B5
NM
Basal
MG-132
Proteasome
Proteasome
12566.17
uM
0.01702
0.03186
-0.6444 -0.5157 1.1297 0.9111
0.9667
1.4648
184B5
NM
Basal
Pevonedistat
NAE1
NAE1
12566.135
uM
0.15715
0.62079
-0.4838 -0.5023 0.5062 0.5445
0.9747
1.6384
184B5
NM
Basal
Nelfinavir
12979.174
uM
5.2970
7.9410
-0.7445 -0.8032 2.3659 0.1847
0.9934
1.5680
184B5
NM
Basal
Nilotinib
ABL
nRTK
12566.17
uM
inf
0.08710
0.9223 0.9254 0.8046 0.0464
0.8541
1.4648